News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Alliances
Ablynx (ABLYF) Signs Exclusive License Agreement With Eddingpharm (Cayman) Inc. To Develop And Commercialise Its Anti-Tnfa Nanobody In Greater China 9/2/2014
Amarillo Biosciences (AMAR) Initiates CLIA Development Of Alzheimer's Blood Diagnostic Lympro Test® At ICON Central Laboratories 9/2/2014
Bristol-Myers Squibb Company (BMY) Gives Back Rights To Alder Biopharmaceuticals Inc.'s Promising Arthritis Drug Clazakizumab 9/2/2014
Chimerix, Inc. (CMRX) And Biomedical Advanced Research and Development Authority (BARDA) Announce Continued Partnership In The Development Of Brincidofovir For Smallpox 9/2/2014
Advanced Biological Laboratories SA (ABL) And Mayo Medical Laboratories Announce Collaboration And Licensing Agreements 9/2/2014
EMD Group (EMD Millipore Headquarters) And Massachusetts General Hospital Collaborate To Better Understand Systemic Lupus Erythematosus And Lupus Nephritis 9/2/2014
CleveXel Pharma Partners With Guilin Pharmaceutical To Develop Two New Anti-Malarial Products 9/2/2014
Intrexon Corporation Announces Exclusive Channel Collaboration With Sanofi (France) (SAN.PA) To Optimize Production For A Specific Family Of Active Pharmaceutical Ingredients 9/2/2014
Minomic: Collaboration With U.S. Partner For New Prostate Cancer Treatment 8/29/2014
22nd Century Group, Inc. Partner NASCO Products Enters Into Agreement With Smoker Friendly International 8/29/2014
Innovus Pharma Signs Exclusive Marketing And Distribution Agreement With Danalife Aps To Market And Distribute Zestra® For Alternative Markets 8/28/2014
Formal Transfer Of Global Rights For Tozadenant To BioTie Therapies Corp. Concluded 8/28/2014
BioTime (BTX) To Collaborate With The University of Wisconsin And Louvain University In Test Of Hystem®-Based Hydrogel For Vocal Fold Scarring 8/28/2014
Dow Microbial Control Forges Commercial Agreement With Xgenex For U.S. Sales Of Dow AOS Certified Technology 8/28/2014
Mafraq Hospital Improves Diabetic Care After University Collaboration 8/28/2014
United States Department Of Commerce Partners With Virocyt To Expand Asian Markets 8/28/2014
Atossa Genetics, Inc. (ATOS) Announces Commercial Partner for Laboratory Services Offered By The National Reference Laboratory For Breast Health, Inc. 8/28/2014
Amerigen Pharmaceuticals And The Ningbo MENOVO Pharmaceutical Co.,LTD., Today Announced They Had Entered Into A Collaboration Agreement Regarding The Development Of Generic Pharmaceuticals, Primarily Targeting The United States Market 8/27/2014
Drug Giants Merck & Co., Inc. (MRK) And Pfizer Inc. (PFE) Forge Cancer Pact 8/27/2014
LabSmith, Inc. Products Now Distributed In South Korea By Revodix, Inc. 8/27/2014
Bavarian Nordic (BAVA.CO) Receives Order From The Canadian Government To Supply IMVAMUNE® Smallpox Vaccine 8/26/2014
A*STAR, BCA And Hitachi, Ltd. (HIT) Pilot Plant Facilitates Research For Greener Buildings 8/26/2014
MRC Technology Negotiates License With Bio-Techne For MRC’s GOPAL Protein Synthesis Technology 8/26/2014
Concert Pharmaceuticals, Inc. (CNCE) Achieves $2 Million Milestone For AVP-786 Under AVANIR Pharmaceuticals (AVNR) Collaboration 8/26/2014
AB SCIEX And Dalton Pharma Services Collaborate To Advance Antibody-Drug Conjugate Analysis 8/26/2014
iBio, Inc. (IBIO) Enters Into $10 Million Common Stock Purchase Agreement With Aspire Capital 8/26/2014
Novozymes A/S (NVZMY) And Monsanto Company (MON) Showcase New Ag Innovations Expected To Increase Sustainability On The Farm 8/26/2014
Anavex Life Sciences Corp. (AVXL.OB) Selects The Alfred Hospital In Melbourne, Australia As Lead Site For Phase 2a Alzheimer's Clinical Trial 8/26/2014
Viropro Inc. (VPRO) Initiates Interim Debt Financing Of Up To $500,000 8/26/2014
ViveBio And Laboratory Procurement Services Sign Agreement For Distribution Of The ViveST Line Of Products 8/26/2014
Recipharm AB Forms New Collaboration With Isofol Medical AB To Exclusively Manufacture Modufolin® And Invests SEK 8 Million In The Company 8/26/2014
Tiny Biotech Advaxis, Inc. Inks Another Pact With Merck & Co., Inc. (MRK) To Test Immune Therapies Against Prostate Cancer 8/26/2014
Cardiome Pharma Corp. (COM.TO) Enters Commercialization Agreement With Eurolab Especialidades Medicinales For Brinavess™ In Argentina 8/25/2014
Telik, Inc. (TELK) Receives $1.5 Million National Cancer Institute Contract To Develop Novel Antibody-Based PET Imaging Agent For Pancreatic Cancer 8/25/2014
Tauriga Sciences Inc. (TAUG) Executes Investment Banking Agreement With Tokyo, Japan Based Dragoon Capital Inc. 8/25/2014
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Gains $20 Million Through Deal With Janssen Research & Development 8/22/2014
Sucampo Pharmaceuticals, Inc. (SCMP) Announces New Exclusive Global Manufacturing And Supply Agreement For Lubiprostone 8/22/2014
Luye In-Licenses China Rights To Cancer Drug From Korea's Hanmi Pharmaceutical, Co., Ltd 8/22/2014
Illumina, Inc. (ILMN) Partners With AstraZeneca PLC (AZN), Johnson & Johnson (JNJ) To Create New Genetic Tests For Cancer 8/21/2014
Gallus Biopharmaceuticals, LLC Enters Agreement With Progenics Pharmaceuticals, Inc. (PGNX) For Manufacture Of Anti-PSMA Monoclonal Antibody 8/21/2014
Sarepta Therapeutics (SRPT) Enters Into Partnership With Flagship Biosciences LLC To Digitally Automate The Measurement Of Dystrophin, A Key Therapeutic Efficacy Marker For Muscular Dystrophy 8/21/2014
Antitope And University College London Enter Into A Research & Licence Agreement For The Generation Of Fully Humanized Antibodies Using Antitope’s Composite Human Antibody™ Technology 8/21/2014
Vensun Pharmaceuticals Enters Into Manufacturing, Supply and Distribution Agreement With ScieGen Pharmaceuticals, Inc. 8/21/2014
Massachusetts Biotechnology Council, Inc. Announces New Collaborations With Nature Publishing Group & Journal Of Commercial Biotechnology 8/21/2014
New Amsterdam Sciences Continues Pact With Dr. Jacob Finkelstein, PhD To Advance Pulmonary Fibrosis Research 8/21/2014
Angiocrine Bioscience Licenses New Stem Cell Technology From Weill Cornell Medical College 8/21/2014
DESY And IBM Corporation (IBM) Develop Big Data Architecture For Science 8/21/2014
AstraZeneca PLC (AZN), Mitsubishi Tanabe Pharma Corporation Link Up For Diabetes Research 8/20/2014
Emergent BioSolutions (EBS), MorphoSys AG Strike Prostate Cancer Pact Worth $183 Million 8/20/2014
Novartis AG (NVS), Global Alliance For TB Drug Development Link Up To Search For TB Cure 8/20/2014
Crohn's and Colitis Foundation of America Release: Expanding IBD Research Through Collaboration 8/20/2014
Bristol-Myers Squibb Company (BMY) And Celgene (CELG) Enter Clinical Collaboration Agreement To Evaluate Immunotherapy And Chemotherapy Combination Regimen 8/20/2014
Global Institute Of Forensic Research Contracts With The Council Of State Governments To Provide Executive Bulletin Service 8/20/2014
Igenbio, Inc. And Genome Compiler Corp. Enter Into A Collaborative Agreement To Offer Synthetic Biology Solutions 8/20/2014
Roche (RHHBY) And Garvan Institute of Medical Research Partner To Develop Genomics Technologies For Targeted Epigenomic Analysis 8/19/2014
Mount Tam Biotechnologies Awarded Worldwide Exclusive License For Research Assets From the Buck Institute -- Advancing Promising Medical Compounds For The Treatment of Lupus Towards The FDA Drug Approval Process 8/19/2014
Evotec AG (EVTG.F) And Medicines for Malaria Venture (MMV) Announce A Long-Term Compound Management Collaboration 8/19/2014
A*STAR And Sumitomo Mitsui Banking Corporation Ink MOU To Support Japanese R&D Collaborations With Singapore 8/19/2014
CAPSUGEL And Cardax Pharmaceuticals Inc. To Collaborate On Development Of Proprietary Astaxanthin Products 8/19/2014
Biomedical Advanced Research and Development Authority (BARDA) Extends Contract With Cytori Therapeutics, Inc. (CYTX) For Burn Treatment, Deal Is Worth Up To $20.4 Million 8/19/2014
Vectura Group plc (VEC.L) Interim Management Statement 8/19/2014
Abbott Laboratories (ABT) Strikes $20 Million Pentagon Deal For Brain Injury Device 8/18/2014
Provectus Biopharmaceuticals Inc. Signs Memorandum Of Understanding With Sinopharm-China State Institute Of Pharmaceutical Industry, And Sinopharm A-THINK Pharmaceutical Co., Ltd. 8/18/2014
HUYA Bioscience International Announces Partnership With Changzhou Center For Biotech Development 8/18/2014
MMS Holdings, Inc. And Oncology Trials Insights Form Strategic Partnership To Deliver Comprehensive Oncology Support Services 8/18/2014
Immune Targeting Systems (ITS) Ltd. And WCCT Global Announce A New Influenza A H1N1 Virus To Support The Experimental Human Viral Challenge Model 8/18/2014
Expression Therapeutics Selects Advanced BioScience Laboratories, Inc. To Support Cell Line Development For Hemophilia A Factor VIII Infusion Therapy 8/18/2014
Pharpoint Research Wins Project Award From Otologic Pharmaceuticals 8/18/2014
ImmuDyne, Inc. (IMMD) Announces Launch Of Clinical Study 8/15/2014
Innovus Pharma And Consortia Health Initiate A Nationwide Marketing And Sales Campaign To U.S. Gynecologists For Zestra®, Clinically Proven For The Enhancement Of Female Arousal Desire And Satisfaction 8/15/2014
Amarillo Biosciences (AMAR) Exercises Option To License Intellectual Property From University Of Miami Bascom Palmer Eye Institute For Use Of MANF In Retinal Disorders 8/15/2014
Isis Pharmaceuticals, Inc. (ISIS) Earns $2 Million From The Advancement Of ISIS-SMN Rx In Children With Spinal Muscular Atrophy 8/15/2014
Ligand Pharmaceuticals Inc. (LGND) Signs Multi-Program Captisol® License Agreement With Avion Pharmaceuticals 8/14/2014
TNI BioTech Expands Partnership With Hubei Qianjiang Pharma 8/14/2014
Roche (RHHBY) Backs Out Of $600 Million Acromegaly Drug Development Deal With Chiasma Inc. 8/14/2014
TNI BioTech And Hubei Qianjiang Pharmaceutical Co., Ltd Supplemental Collaborative Agreement 8/13/2014
RedHill Biopharma Ltd. (RDHL) Acquires Option For Phase 2 Pancreatic Cancer Drug RP101 8/13/2014
Retroscreen Virology Limited Partners With ERT For Centralised ECG Services In Hvivo Challenge Studies 8/13/2014
23andMe, Inc., Pfizer Inc. (PFE) Strike Pact To Research The Genetics Of Inflammatory Bowel Disease 8/12/2014
ProSensa Holding N.V. (RNA) And CureDuchenne Strengthen Long-Term Collaboration With An Additional [Eur]5M To Advance DMD Pipeline 8/12/2014
Marinus Pharmaceuticals (MRNS) Enters Into Use Agreement With CyDex Pharmaceuticals For Use Of Captisol® For Ganaxolone IV 8/12/2014
Fred's And Cardinal Health, Inc. (CAH) Announce Primary Supply Agreement 8/12/2014
FORMA Therapeutics, Inc. And Paradigm Announce Molecular Profiling Collaboration For Drug Candidates 8/12/2014
Feist-Weiller Cancer Center Partners With Caris Life Sciences To Establish A Clinical Molecular Profiling Program 8/12/2014
Myelin Repair Foundation Announces Long-Term European Partnership With Hertie Foundation 8/12/2014
Protein Sciences Corporation And Liomont Announce Licensing Of Proprietary Influenza Vaccines For The Mexico Market 8/12/2014
ITEN And Biogenerator Work Together At Intersection Of IT And Bioscience Startups 8/12/2014
Novartis AG (NVS), GlaxoSmithKline (GSK) Reshape Pharma With Game-Changing $14.5 Billion Deal 8/12/2014
Sanofi (France) (SAN.PA) To Pay MannKind Corporation (MNKD) Up To $925 Million For Inhaled Insulin 8/12/2014
Galapagos NV (GLPG.BR), GlaxoSmithKline (GSK) Abandon Joint Drug Project Due To Adverse Effects 8/11/2014
Human Longevity Inc. And Celgene Cellular Therapeutics Sign License Agreement To Develop And Commercialize Placental Stem Cell Population, PSC-100 For Multiple Therapeutic Applications 8/11/2014
Sigma-Tau Pharmaceuticals Signs Exclusive Agreement With Crosscare Limited For U.S. Marketing And Distribution License Of Colief® Infant Drops For The Treatment Of Colic-Associated Crying 8/11/2014
Amarantus BioSciences, Inc. Enters Into Research Collaboration With The Buck Institute for Age Research For MANF 8/11/2014
ALR Technologies Inc. To Conduct Clinical Trial With Premier Hospital Of Chilean Health Ministry In Santiago 8/11/2014
Cryoprinting Red Blood Cells: Akron Biotechnology, LLC And Stanford University Collaborative Study 8/11/2014
Radient Technologies Inc. Awarded Contract By Fortune 500 Consumer Staples Company 8/11/2014
Cancer Research Technology And Cancer Research UK Cambridge Research Institute Join Forces With Astellas Pharma Inc. (ALPMY) On Autophagy To Find New Cancer Treatments 8/8/2014
3SBio Inc. (SSRX) Signs Exclusive Patent License Agreement With DinoNa For Leukotuximab 8/8/2014
U.S. Government Exercises Contract Options Valued At $18.9 Million For Emergent BioSolutions (EBS)' Vaccinia Immune Globulin Intravenous Program 8/8/2014
Eirgenix Signs Agreement With Taimed To Provide Development And Manufacturing Services For Taimed’s Second Generation anti-HIV mAb TMB-360 8/7/2014
Daiichi Sankyo, Inc. (4568.t) Wagers Up To $650 Million On Charleston Laboratories, Inc.'s Pain And Opioid-Induced Nausea And Vomiting Drug 8/7/2014
National Institutes of Health (NIH) And Mesoblast Limited (MSB.AX) Enter Into Agreement for 120-Patient Trial In End-Stage Heart Failure 8/7/2014
Access Pharmaceuticals (ACCP) Announces European License Agreement With Norgine 8/7/2014
Blacktrace Holdings Ltd. To In-License PerkinElmer, Inc. (PKI)Technology 8/7/2014
Leica Biosystems And Bristol-Myers Squibb Company (BMY) Enter Into A Development And Commercialization Collaboration For Companion Diagnostics That Support Targeted Therapies 8/7/2014
Vivex Biomedical And Akron Biotech: Collaborative Venture In Regenerative Medicine 8/7/2014
Idera Pharmaceuticals, Inc. (IDRA) And The Myositis Association Join Forces To Advance The Clinical Development Of A Novel TLR Antagonist, IMO-8400, For The Treatment Of Myositis 8/7/2014
Terumo BCT Announces Collaboration To Evaluate Clinical Cell Production Using Quantum System 8/7/2014
Sanofi (France) (SAN.PA), Immune Design Corporation (IMDZ) Strike Food Allergy Deal Worth $168 Million+ 8/7/2014
Pfizer Inc. (PFE), Roche (RHHBY) Join Consortium In Effort To Up Success Of Late-Phase Clinical Work 8/6/2014
Bavarian Nordic (BAVA.CO) Is The Sole Bidder For Canadian Smallpox Vaccine Supply 8/6/2014
Sanofi (France) (SAN.PA), Emcure Pharmaceuticals Limited Ink Marketing Pact For Cancer Drugs 8/6/2014
Catylix, Inc. And Aspira Scientific Announce Cooperation To Produce And Distribute Hartwig Trifluoromethylator® Reagent 8/6/2014
Oxygen Biotherapeutics, Inc. (OXBT) Announces Collaboration With Imperial College London To Accelerate Enrollment Of Leopards Trial 8/6/2014
OX-MPI Project Returned To Orexo AB (ORXOF) 8/6/2014
Aegis Therapeutics, LLC Release: First Non-Injectable GLP-1 Analog For Type-2 Diabetes 8/6/2014
Meridian Bioscience, Inc. (VIVO) And The University Of Tennessee Research Foundation Enter Into A License Agreement For Electrokinetic Sensor Technology 8/6/2014
Oxygen Biotherapeutics, Inc. (OXBT) Announces Collaboration With Imperial College London To Accelerate Enrollment Of Leopards Trial 8/6/2014
Biopredic International And Triangle Research Labs Announce The Distribution Of No-Spin Cryopreserved Heparg™ Cells By TRL In The United States 8/6/2014
Yabao Pharmaceuticals And Changzhou Le Sun Pharmaceuticals Ltd. Enter An Innovative Partnership To Develop Early-Stage Oncology Compound 8/6/2014
Heritage Pharmaceuticals Signs Exclusive Development Supply & Distribution Agreement With Dexcel Ltd. 8/5/2014
AEterna Zentaris (AEZS) And ASCEND Therapeutics, Inc. Sign Co-Promotion Agreement For U.S. Market 8/5/2014
Regulus Therapeutics, Inc. Enters Into New Collaboration Agreement With Biogen Idec, Inc. (California) (BIIB) To Identify Microrna Biomarkers In Multiple Sclerosis 8/5/2014
Dyadic International, Inc. And CIMV Enter Into Collaboration To Commercialize Second Generation Biofuel Technology 8/5/2014
ViaDerma, Inc. Announces Strategic Partnership With The Brewer Group 8/5/2014
Cesca Therapeutics And Fortis Healthcare Announce Master Collaboration Agreement 8/5/2014
Ultragenyx Pharmaceuticals (RARE) Announces License Of Intellectual Property For The Treatment Of Epilepsy And Other Seizure-Related Disorders With Triheptanoin 8/5/2014
Galapagos NV (GLPG.BR) Receives Milestone In Osteoarthritis Alliance With Servier 8/5/2014
PatientsLikeMe And Actelion Ltd. (ALIOF.PK) To Develop New Patient-Reported Measure For Mycosis Fungoides–Type Cutaneous T-Cell Lymphoma (MF-CTCL) 8/5/2014
Geron Corporation (GERN) To Assume Sponsorship Of Myelofibrosis IST And IND 8/5/2014
Arena Solutions And SiliconExpert Partner To Reduce Supply Chain Risk 8/5/2014
CritiTech And European Medical Contract Manufacturing Announce Collaboration To Develop API-Coated Tissue Grafts 8/5/2014
Molecular Targeting Technologies, Inc. And National Health Research Institutes Have Joined Forces In Developing Novel Cancer Therapeutics 8/5/2014
Ignyta (RXDX) And Nerviano Medical Sciences (NervianoMS) Announce License Agreement For Two First-in-Class Kinase Inhibitors 8/5/2014
Ariad Pharmaceuticals, Inc. (ARIA) Announces Commercial Agreement For Iclusig (Ponatinib) In Israel 8/5/2014
NewLink Genetics, Through Its Wholly Owned Subsidiary, BioProtection Systems Corporation, Secures a Letter Contract From The Defense Threat Reduction Agency For Testing And Evaluation Of Ebola Virus Vaccine 8/5/2014
Organogenesis Inc. Awarded A 5-Year Federal Supply Schedule Agreement With The Department Of Veteran Affairs 8/4/2014
Facebook And Reckitt Benckiser Pharmaceuticals Inc. Partner On Innovative Global Approach To Effectively Reach Consumers In Their Digital Lives 8/4/2014
FEI Company Reports New Advances In Neuroscience In Collaboration With National Institutes of Health (NIH) 8/4/2014
AmorChem l.p., Université Laval And CHU De Québec Collaborate On The Development Of A Treatment For Friedreich’s Ataxia 8/4/2014
California Institute of Technology Release: Prominent U.S. Research Institutions Announce Collaboration Toward Sharing And Standardizing Neuroscience Data 8/4/2014
BioGasol Establishes Licensed Carbofrac® Reactor Manufacture By Sweetwater Energy 8/4/2014
Metabolix, Inc. Enters Into Private Placement Agreement With Investors To Raise $25 Million In Equity Financing 8/4/2014
Medivir AB (MVRBF) Licenses Respiratory Syncytial Virus Drug Program From Boehringer Ingelheim Corporation 8/4/2014
Vernalis PLC (VNLPY.PK) And Servier Achieve Two Research Milestones In Their Oncology Collaborations 8/4/2014
Kadimastem To Collaborate With Merck Serono To Advance Combined Efforts In Neurodegenerative Disease Area 8/4/2014
KannaLife Sciences, Inc. Signs New License Agreement With National Institutes of Health (NIH) For Treatment Of Chronic Traumatic Encephalopathy 8/4/2014
Kapa Biosystems Strengthens Investment Across Asia Pacific Region By Extending Exclusive Japanese Distribution Agreement With NIPPON Genetics 8/4/2014
Amarantus BioSciences, Inc. Acquires Exclusive Option To License Alzheimer's Therapeutic IP Of Dr. Thomas Arendt From University of Leipzig 8/1/2014
Solasia Pharma K.K. Grabs Global Rights To ZIOPHARM Oncology, Inc. (ZIOP.OB)'s Zinapar For Up To $72.2 Million 8/1/2014
ChromaDex, Inc. Signs Material Transfer Agreement With Prominent Australian Research Institute For NIAGEN™ Research 7/31/2014
Catylix, Inc. And Aspira Scientific Announce Joint Venture To Commercialize New Fluorination Technologies 7/31/2014
Sirona Biochem Announces Successful Synthesis Of Anti-Inflammatory Compound For Bloom Burton & Co. Joint Venture 7/31/2014
Invitae And Nanopharmacia Announce Partnership To Make Reliable, Fast And Affordable Hereditary Cancer Genetic Testing Broadly Available In Mexico 7/31/2014
Anika Therapeutics (ANIK) Announces U.S. Commercialization Partnership For Hyalomatrix® With Wound Care Leader Medline Industries, Inc. 7/31/2014
Rogne Bioscience, Inc. Release: Oxford Licenses Anti-Inflammatory Peptides To San Francisco Bay Area Start-Up 7/31/2014
Columbia Laboratories, Inc. (CBRX)'s Subsidiary, Molecular Profiles, Strikes Alliance With XenoGesis Ltd. 7/31/2014
AIBioTech Teams With Leidos For Air Force Contract 7/31/2014
Incyte Corporation (INCY) Partners With Genentech (RHHBY) To Help With Cancer Immunotherapy Trials 7/30/2014
PCI Announces Definitive Agreement To Acquire Penn Pharma 7/30/2014
Leidos Awarded $44 Million Contract By The Centers for Disease Control and Prevention (CDC) 7/30/2014
Kaiser Permanente, Johns Hopkins Medicine Announce Enhanced Strategic Collaboration 7/30/2014
Evotec AG (EVTG.F) Receives First Milestones In TargetAD Collaboration 7/30/2014
Theraclone Sciences, Inc. Announces Exclusive Agreement With Gilead Sciences, Inc. (GILD) For Broadly Neutralizing HIV Antibodies 7/30/2014
Massachusetts Biotechnology Council, Inc. Announces New Collaboration With Life Sciences Market Intelligence Firm Evaluate Ltd. 7/30/2014
Baylor Sammons Cancer Center Joins As Clinical Trial Site For Actinium Pharmaceuticals, Inc. (ATNM.OB)’s Actimab-A Clinical Trial 7/30/2014
Lion Biotechnologies, Inc. Enters Clinical Trial Grant Agreement With H. Lee Moffitt Cancer Center & Research Institute 7/30/2014
Durata Therapeutics, Inc.  (DRTX) Enters Into An Exclusive License And Supply Agreement With Angelini To Commercialize Dalbavancin In Certain European Territories, Russia And Turkey 7/30/2014
Anika Therapeutics (ANIK) Announces U.S. Commercialization Partnership For Hyalomatrix® With Wound Care Leader Medline Industries, Inc. 7/30/2014
Florida Institute Funds Miami-based RxMP Therapeutics, LLC 7/30/2014
Proteostasis Therapeutics, Inc. Announces Achievement Of Preclinical Milestone In Neurodegenerative Diseases Collaboration With Biogen Idec, Inc. (Massachusetts) (BIIB) 7/30/2014
AstraZeneca PLC (AZN) Taps Roche (RHHBY) For New Blood-Based Cancer Drug Tests 7/29/2014
Flexion Therapeutics (FLXN) And Southwest Research Institute (Swri®) Sign Worldwide Exclusive License For Proprietary Microsphere 7/29/2014
Malaria Transmission-blocking Vaccines – ARTES Biotechnology And Burnet Announced A Development Project 7/29/2014
SDK And BIA Separations Expanding Their Co-operation 7/29/2014
Roche (RHHBY) And AmorChem l.p. Announce Alliance Focused On Myotonic Muscular Dystrophy 1 7/29/2014
Advaxis, Inc. And The University of Pennsylvania Restructure Their Exclusive License Agreement 7/29/2014
Intrexon Corporation Enters Into Technology Collaboration To Advance Animal Health Applications 7/29/2014
Rosetta Genomics Ltd. (ROSG) Announces Next-Generation Sequencing Research Collaboration With Weizmann Institute of Science's Nancy And Stephen Grand Israel National Center For Personalized Medicine 7/29/2014
Sanofi (France) (SAN.PA) Abandons Antibiotics Deal With South San Francisco's KaloBios Pharmaceuticals, Inc. (KBIO) 7/29/2014
Zealand Pharma  (ZEAL.CO), Boehringer Ingelheim Corporation Strike $402 Million Peptide Pact 7/28/2014
AstraZeneca PLC (AZN), QIAGEN N.V. (QGEN) Strike Lung Cancer Diagnostic Pact For Patients Suitable For Treatment With IRESSA 7/28/2014
CN Bio Innovations Marks World Hepatitis Day By Signing Research Agreement With Imperial College London 7/28/2014
CANbridge Life Sciences And EUSA Pharma Form Agreement To Commericalize Caphosol® In China 7/28/2014
Targeted Medical Pharma Agrees To Sponsor A Clinical Trial Conducted By The United States Army And Henry M. Jackson Foundation For The Advancement Of Military Medicine 7/28/2014
MC10 & UCB, Inc. (UCBJF.PK) Partner For Innovative Solutions For Patients With Neurological Disorders 7/28/2014
Parnell Pharmaceuticals Holdings Acquires License For Intellectual Property And Rights To Develop Compounds For Bone And Dermal Regeneration 7/25/2014
Lion Biotechnologies, Inc. Announces Exclusive License Agreement With H. Lee Moffitt Cancer Center & Research Institute 7/25/2014
MYOS (MYOS) Extends Manufacturing And Supply Agreement For Fortetropin 7/25/2014
Cubist Pharmaceuticals, Inc. (CBST) Strikes Agreement With Competitor To Delay Generic Cubicin 7/24/2014
Gilead Sciences, Inc. (GILD), Medicines Patent Pool Strike Deal: New Opportunity For Indian Drugmakers 7/24/2014
Immune Pharmaceuticals, Inc. Release: Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin 7/24/2014
TransCelerate BioPharma Selects Cognizant (CTSH) To Develop A Clinical Trials Collaboration Platform 7/24/2014
Cipher Pharmaceuticals (DND.TO) And Ranbaxy Laboratories (RANBAXY.BO) Announce Distribution Agreement For Isotretinoin Product In Brazil 7/24/2014
Bristol-Myers Squibb Company (BMY) And Ono Pharmaceutical Company, Ltd. Announce Strategic Immuno-Oncology Collaboration In Japan, South Korea And Taiwan 7/24/2014
Evogene Ltd. (EVGN) Announces Amendment To Bayer Wheat Agreement To Focus On Discovery Of Novel Genomic Promoters 7/24/2014
LSI Medience Corporation And Kineticos Sign Agreement Related To The Presepsin Biomarker In Sepsis Management And Treatment 7/24/2014
Agilent Technologies Inc. (A) Signs Co-Marketing Agreement With MRM Proteomics To Advance Quantitative Proteomics Solutions 7/24/2014
Pfizer Inc. (PFE) Backs Out of Funding Puma Biotechnology (PBYI) Cancer Drug Trials 7/24/2014
Taconic Announces New Agreement To Distribute Next Generation NOG Mouse Models 7/24/2014



//-->